Synergy Investment Management, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 2053786
ALTAMONTE SPRINGS, FL
Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$126,664
+$102,998 QoQ
Shares Held
255
+381.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#1,454
of 1,730 holders
Holding Since
Dec 2024
4 quarters on record
Voting authority
Sole 5%
Shared 0%
None 95%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Synergy Investment Management, LLC holds $193,142 across 13 Biotechnology names. VRTX ranks #1 (65.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
255 | $126,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
62 | $38,658 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
24 | $7,224 | |
| 4 | INSM |
INSMED Inc
|
50 | $5,331 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
80 | $2,831 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
32 | $2,608 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
35 | $2,002 | |
| 8 | ABVX |
Abivax S.A.
|
15 | $1,998 |
All Filings in VRTX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $126,664 | 255 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $23,666 | 53 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $10,666 | 22 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $8,859 | 22 | Shares | Sole | 2025-02-06 | |
| No filing history on record for this holder in this stock. | ||||||